share_log

Ultragenyx Pharmaceutical | 10-K: FY2023 Annual Report

SEC ·  Feb 21 16:07
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more